- TOP SHIPS Inc TOPS shares dipped 57.6 percent to $1.02. TOP SHIPS enacted a 1:15 reverse stock split today.
- ParkerVision, Inc. PRKR shares dropped 13.9 percent to $2.10. ParkerVision disclosed that the German Court decision in infringement case against Apple awaits validity ruling.
- Invivo Therapeutics Holdings Corp NVIV shares dropped 13 percent to $3.17.
- BlackBerry Ltd BBRY shares declined 12.4 percent to $9.69. BlackBerry reported better-than-expected earnings for its third quarter, while revenue missed expectations.
- Bed Bath & Beyond Inc. BBBY shares tumbled 12 percent to $29.69 after the company reported weaker-than-expected results for its first quarter. Deutsche Bank lowered the price target for Bed Bath & Beyond from $36 to $31.
- Ocular Therapeutix Inc OCUL dipped 11.8 percent to $10.18. Ocular Therapeutix disclosed that Antony Mattessich will succeed Dr. Amar Sawhney as CEO of the company. Morgan Stanley downgraded Ocular Therapeutix from Overweight to Equal-Weight.
- Meridian Waste Solutions Inc MRDN shares dropped 11.4 percent to $2.48.
- American Software, Inc. AMSWA fell 7 percent to $11.13. American Software reported preliminary Q4 adjusted earnings of $0.09 per share on revenue of $26.3 million.
- Celsion Corporation CLSN declined 6.8 percent to $2.45. Celsion reported cancellation of registered direct offering on Thursday.
- bluebird bio Inc BLUE shares slipped 6.6 percent to $110.65 after the company issued new data from HGB-205 study of LentiGlobin drug product.
- Leju Holdings Ltd (ADR) LEJU dropped 3.3 percent to $2.38. JP Morgan downgraded Leju Holdings from Neutral to Underweight.
- Clovis Oncology Inc CLVS fell 3.2 percent to $93.71. Oppenheimer initiated coverage on Clovis Oncology with a Perform rating.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in